DE60228408D1 - Gssp4-polynukleotide und -polypeptide sowie deren verwendung - Google Patents

Gssp4-polynukleotide und -polypeptide sowie deren verwendung

Info

Publication number
DE60228408D1
DE60228408D1 DE60228408T DE60228408T DE60228408D1 DE 60228408 D1 DE60228408 D1 DE 60228408D1 DE 60228408 T DE60228408 T DE 60228408T DE 60228408 T DE60228408 T DE 60228408T DE 60228408 D1 DE60228408 D1 DE 60228408D1
Authority
DE
Germany
Prior art keywords
metabolic
disorders
gssp4
obesity
related diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228408T
Other languages
English (en)
Inventor
Barbara A Chicca
John Chicca
Blake Denison
Frances Yen-Potin
Bernard Bihain
Stephane Bejanin
Hiroaki Tanaka
Severin Jobert
Jean-Yves Giordano
Milne Edwards Jean-Bapti Dumas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Serono Genetics Institute SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2001/000914 external-priority patent/WO2002083898A1/en
Application filed by Serono Genetics Institute SA filed Critical Serono Genetics Institute SA
Application granted granted Critical
Publication of DE60228408D1 publication Critical patent/DE60228408D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE60228408T 2001-02-09 2002-02-07 Gssp4-polynukleotide und -polypeptide sowie deren verwendung Expired - Lifetime DE60228408D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26762401P 2001-02-09 2001-02-09
PCT/IB2001/000914 WO2002083898A1 (en) 2001-04-18 2001-04-18 Full-length human cdnas encoding potentially secreted proteins
US29572201P 2001-06-04 2001-06-04
PCT/IB2002/001514 WO2002069689A2 (en) 2001-02-09 2002-02-07 Gssp4 polynucleotides and polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
DE60228408D1 true DE60228408D1 (de) 2008-10-02

Family

ID=27270234

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228408T Expired - Lifetime DE60228408D1 (de) 2001-02-09 2002-02-07 Gssp4-polynukleotide und -polypeptide sowie deren verwendung

Country Status (6)

Country Link
EP (1) EP1357973B1 (de)
AT (1) ATE405323T1 (de)
AU (1) AU2002307819A1 (de)
DE (1) DE60228408D1 (de)
ES (1) ES2312594T3 (de)
WO (1) WO2002069689A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE478890T1 (de) 2002-05-31 2010-09-15 Serono Genetics Inst Sa Homotrimerer, erweiterter globulärer kopf von obg3 und verwendungen davon
JP2004292361A (ja) * 2003-03-27 2004-10-21 Takeda Chem Ind Ltd 摂食調節剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289517T1 (de) * 1996-11-12 2005-03-15 Novo Nordisk As Verwendung von glp-1 peptiden
WO2000052022A1 (en) * 1999-03-01 2000-09-08 Millennium Pharmaceuticals, Inc. Secreted proteins and nucleic acids encoding them
AU3246100A (en) * 1999-06-02 2000-12-28 Genentech Inc. Methods and compositions for inhibiting neoplastic cell growth

Also Published As

Publication number Publication date
WO2002069689A3 (en) 2003-02-06
EP1357973A2 (de) 2003-11-05
ATE405323T1 (de) 2008-09-15
EP1357973B1 (de) 2008-08-20
WO2002069689A2 (en) 2002-09-12
ES2312594T3 (es) 2009-03-01
AU2002307819A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
WO2003057666A3 (en) Inhibitors of dipeptidyl peptidase iv
DE60121096D1 (de) Methode zur Behandlung von Fettsucht anhand eines Neurotensinreceptor-Liganden
WO2004052284A3 (en) Treatment of diabetes
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
NZ335992A (en) Substituted pyrimidinone and pyridone compounds and methods of use
ATE374766T1 (de) 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
WO2006128125A3 (en) Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
RU2008150621A (ru) Лечение депрессивных расстройств
MXPA05007689A (es) Tratamiento de enfermedades con agonistas completos del receptor alfa-7 de nach.
DK1485051T3 (da) Fremgangsmåde til indgivelse af buprenorphin til behandling af depression
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
WO2002074323A3 (en) Using neural thread proteins to treat tumors and other hyperproliferative disorders
DE60228408D1 (de) Gssp4-polynukleotide und -polypeptide sowie deren verwendung
WO2002087503A3 (en) Compositions and methods for treating colorectal polyps and cancer
WO2003050281A3 (en) Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
WO2003033534A3 (en) Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
WO2004043365A3 (en) Method for treatment of premature ejaculation in humans
WO2003075951A3 (en) Novel application of vaccination against tnf-alpha
WO2003082915A3 (en) Xcrf polynucleotides and polypeptides and uses thereof
WO2002066505A3 (en) Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
WO2002055694A3 (en) Discriminative nucleic acid analysis using clone sequence signatures
WO2003095485A3 (en) Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
WO2002060466A3 (en) Gssp3 polynucleotides and polypeptides and uses thereof
WO2003062469A3 (en) Gene matn3 or matrilin-3 linked to osteoarthritis treatment

Legal Events

Date Code Title Description
8364 No opposition during term of opposition